About me

About This Research

A Personal Journey Through Cancer Treatment Innovation

The Personal Catalyst: At age 13, my father and both grandfathers had already died, far too young, of cancer. Many years later, when my father-in-law was diagnosed with glioblastoma multiforme, I became deeply involved in his treatment strategy.

The Glioblastoma Challenge

Glioblastoma patients face devastating odds, with a five-year survival rate of just 3 percent. The urgent need to explore complementary treatment options was undeniable.

2003: Diagnosis 2025: Still Alive & Well 21+ Years Survival 0.1% 10Y Expected Survival Rate

Research Philosophy

If someone survives a type of cancer that is almost always fatal, there must be something we can learn. This belief motivated me to document and share his detailed case report.

I approach cancer treatments like a trader seeking an edge in financial markets - systematically analyzing patterns, identifying synergies, and evaluating risk-to-benefit ratios across thousands of research papers.

The Synergy Perspective: A cancer diagnosis is frightening, but patients have significant options beyond standard medical care. Diet, nutritional supplements, environmental modifications, and lifestyle interventions can profoundly influence cancer development and progression. Strategic combinations may help support or restore the body's natural capacity to fight cancer.

What This Blog Offers

This research database represents years of systematic analysis across multiple domains:

• Critical evaluation of 1000+ peer-reviewed studies
• Detailed profiles of 100+ natural anti-cancer compounds
• Synergistic combination strategies based on complementary mechanisms
• Translation gap analysis highlighting differences between laboratory and clinical reality
• Cancer-specific treatment approaches for various tumor types
• Drug repurposing opportunities in oncology

The Translation Challenge

This blog maintains a unique focus on the "translation gap" - the critical difference between promising laboratory research and achievable clinical applications. Many compounds show remarkable anti-cancer effects in cell culture or animal studies but face significant bioavailability, dosing, or safety limitations in humans.

Understanding these limitations is essential for making informed decisions about complementary cancer treatments.

Important Perspective: From a layman's perspective, nothing on this blog should be taken as expert medical advice. Like capital markets, beating cancer odds sometimes involves elements of luck, timing, and individual biological variability that cannot be fully predicted or replicated.

Medical Disclaimer: This blog provides educational content only. Nothing here constitutes medical advice or should be used for medical diagnosis or treatment. Cancer patients should always work closely with qualified oncologists and healthcare providers when making treatment decisions.

Best wishes for your health and healing journey,

Johan

Researcher & Advocate for Integrative Cancer Care